Company: BIVIW
Filing Date: 2025-07-22
Form Type: S-1/A
Source: 0001520138-25-000216
Chunk: 75

Company: BIOVIE INC.
Filing Date: 2025-07-22
Form: S-1/A
Chunk 75
---
 of $10.30 per Unit, which was the closing price of shares of our Common Stock on Nasdaq on June
26, 2025, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, assuming no
sale of the Pre-funded Units.

We intend to use the net proceeds from this offering for working capital
and general corporate purposes. This may include, but is not limited to, capital expenditures, research and development expenditures and
acquisitions of new technologies or businesses.

A $1.00 increase (decrease) in the assumed public
offering price of $10.30 per Unit, which was the closing price of our common stock on Nasdaq on June 26, 2025, would increase (decrease)
the net proceeds from this offering by approximately $1.4 million, assuming that the number of Units offered by us, as set forth
on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated
offering expenses payable by us. An increase (decrease) of 50,000 Units in the number of Units offered by us, as set forth on the
cover page of this prospectus, would increase (decrease) the net proceeds from this offering by approximately $0.48 million, assuming
no change in the assumed public offering price per Unit and after deducting estimated underwriting discounts and commissions and estimated
offering expenses payable by us.

Although we have identified some potential uses
of the net proceeds to be received from this offering, we cannot specify these uses with certainty. The allocations of the proceeds of
this offering presented above constitute the current estimates of our management and are based on our current plans, assumptions made
with respect to the industry in which we currently or, in the future, expect to operate, general economic conditions and our future revenue
and expenditure estimates. Our management will have broad discretion in the application of the net proceeds from this offering and could
use them for purposes other than those contemplated at the time of this offering. Our stockholders may not agree with the manner in which
our management chooses to allocate and spend the net proceeds. Moreover, our management may use the net proceeds for corporate purposes
that may not positively impact our results of operations or increase the market value of our securities.

<div align='center'>37

Dividend Policy</div>

We have never declared or paid dividends on our
Common Stock and we do not anticipate paying any cash